FDA
approval
· 2026-04-23
FDA Approved: OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE — Supplemental Application (Ascend Laboratories, LLC)
Summary
The FDA approved a supplemental application to market a fixed-dose combination tablet of olmesartan medoxomil and hydrochlorothiazide for the treatment of hyper…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE (OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE)